ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

PHASE3CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2007

Conditions
Myocardial IschemiaHypertension
Interventions
DRUG

Irbesartan

Trial Locations (11)

Unknown

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, Brussels

Sanofi-Aventis, Laval

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Budapest

Sanofi-Aventis, Milan

Sanofi-Aventis, Gouda

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Meyrin

Sanofi-Aventis, Guildford

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00296218 - ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation | Biotech Hunter | Biotech Hunter